SMTL ID : 6aak.1 (1 other biounit)

Crystal structure of JAK3 in complex with peficitinib

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.67 Å

Oligo State

homo-dimer

Ligands

2 x 9T6: 4-[[(1S,3R)-5-oxidanyl-2-adamantyl]amino]-1H-pyrrolo[2,3-b]pyridine-5-carboxamide(Non-covalent)

9T6.1: 12 residues within 4Å: Chain A: L.15, A.40, V.71, M.89, E.90, Y.91, L.92, G.95, R.140, N.141, L.143, D.154 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:L.15, A:A.40, A:L.143, A:L.143, A:D.154 Hydrogen bonds: A:E.90, A:L.92, A:L.92 9T6.2: 13 residues within 4Å: Chain B: L.15, G.16, V.23, A.40, V.71, M.89, E.90, Y.91, L.92, G.95, R.140, N.141, L.143 9 PLIP interactions: 9 interactions with chain B Hydrophobic interactions: B:L.15, B:L.15, B:V.23, B:A.40, B:L.143, B:L.143 Hydrogen bonds: B:E.90, B:L.92, B:L.92

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Hamaguchi, H. et al., Discovery and structural characterization of peficitinib (ASP015K) as a novel and potent JAK inhibitor. Bioorg. Med. Chem. (2018)

Release Date

2018-08-15

Peptides

Tyrosine-protein kinase JAK3: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Tyrosine-protein kinase JAK3

Related Entries With Identical Sequence